eNauka - pregled
Pregled prema Autor Ruiz, EP Yanez
Prikaz rezultata 1 do 1 od 1
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2024 | 3-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer | Verschraegen, C; Andric, Zoran G   ; Moiseenko, FV; Makharadze, T; Oleksiienko, A; Ruiz, EP Yanez; Kim, SH; Ahn, K; Park, TH; Ju, HA;
Baek, EH; Kwon, S; Lee, SJ; Chang, I; Kim, SH; Kim, HA; Lee, E; Ohe, Y;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |